Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relaxin in Systemic Sclerosis
NCT00704665Phase 3Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Dec 1998
- Primary completion
- Dec 2001
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of serelaxin in systemic sclerosis (SSc), sponsored by University of Medicine and Dentistry of New Jersey. Started Dec 1998; status: completed.
02
Drugs
serelaxin
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00704665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00704665.